A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)

Clinical trial NCT07129343 · RECRUITING

Trial details

NCT number: NCT07129343
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Von Willebrand Disease (VWD)

Start date: 2025-10-13
Primary completion: 2027-11-25
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.